This study is recruiting. It focuses on bipolarity and currently lists participation information in France.
This study is looking at whether psychoeducation can help people with Neurologic Disorders, Schizophrenia, bipolarity, or depression. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to psychoeducation, but direct benefit is not guaranteed.
The official record suggests in-person participation through a hospital, with sites including Departement of Adult Psychiatry, GH Pitié Salpétrière in Paris, Groupe hospitalo-universitaire Paris Psychiatrie et Neurosciences, and Hôpital Fondation Adolphe de Rothschild in Paris. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include major medical issues that could make participation unsuitable and active substance or alcohol problems that could affect the results. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it is evaluating Cognitive assessment, Brain MRI (optional), Electroencephalography (optional), Magnetoencephalography (optional) in a structured research setting. For people exploring bipolarity research, clear information about the goal, status, contacts, and official source can support better questions before any decision.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may help test a support approach in real life.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in France.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring behavioral or lifestyle intervention for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Centre Hospitalier St Anne. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.